Hui Zhou

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Jianming Xu, Yi Li, Qingxia Fan et al. · Nature Communications · 2022 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Expression and Functional Role of ALDH1 in Cervical Carcinoma Cells

Qunxian Rao, Tingting Yao, Bing-Zhong Zhang et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 45 citations · Full text

Medicine, Cell Biology, Oncology +17

Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer

Meng Lei, Huayun Feng, Enhe Bai et al. · Organic & Biomolecular Chemistry · 2018 · 33 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Treatment of murine lupus with PD-LIg

Hui Zhou, Lijuan Xiong, Yuxiao Wang et al. · Clinical Immunology · 2015 · 31 citations

Life Sciences, Immunology, Pharmacotherapy +10

Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study

Hui Zhou, Zhifeng Li, Hui Liang et al. · Platelets · 2021 · 30 citations

Medicine, Hematology, Clinical Epidemiology +13